Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Planned sale SVP, CFO, CBO & Treasurer sold 41,314 shares at $3.67 ($151,622)
  4. 144 Insider Sale of Securities
  5. 8-K Event Executive or director change · Shareholder vote results
  6. 4 Grant or award Director acquired 35,700 shares (grant or award)
  7. 4 Grant or award Director acquired 35,700 shares (grant or award)
  8. 4 Grant or award Director acquired 35,700 shares (grant or award)
  9. 4 Grant or award Director acquired 35,700 shares (grant or award)
  10. 4 Grant or award Director acquired 35,700 shares (grant or award)
  11. 4 Grant or award Director acquired 35,700 shares (grant or award)
  12. 4 Grant or award Director acquired 35,700 shares (grant or award)
  13. 4 Planned sale SVP, Chief Accounting Officer sold 15,000 shares at $4.01 ($60,150)
  14. 4 Planned sale SVP, Chief Accounting Officer sold 13,334 shares at $3.53 ($47,069)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. ARS Other Annual Report to Security Holders
  19. DEFA14A Proxy Proxy Materials
  20. DEF 14A Proxy Proxy Statement

Page 4 of 45 · 886 filings